Latest filing published 06 Oct 2023 for Horizon Therapeutics Public Ltd Co, €3.5M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of William F. Daniel in Horizon Therapeutics Public Ltd Co, where the filings describe the role as board member. We count 26 filings; the first trade dates from 19 September 2015 and the latest from 6 October 2023.
No open-market purchase appears, only 2 sales worth €1.4M. Besides market trades, the filings include 10 share grants and 12 option exercises.
The latest filing, published on 6 October 2023, reports a transaction of €5.3M in Horizon Therapeutics Public Ltd Co. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations